| Price | 6.80p on 08-05-2026 at 13:54:01 |
|---|---|
| Change | 0.05p 0.74% |
| Buy | 6.90p |
| Sell | 6.70p |
| Last Trade: | Sell 743.00 at 6.70p |
| Day's Volume: | 2,146,716 |
| Last Close: | 6.75p |
| Open: | 6.80p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.75p - 6.80p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £72.65m |
| VWAP: | 6.764775p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 743 | 6.70p | Ordinary |
14:53:59 - 08-May-26 |
| Buy* | 14,718 | 6.835p | Ordinary |
14:52:10 - 08-May-26 |
| Buy* | 165 | 6.90p | SI Trade |
14:46:06 - 08-May-26 |
| Buy* | 219,305 | 6.836p | Ordinary |
14:45:36 - 08-May-26 |
| Buy* | 14,561 | 6.84p | Ordinary |
14:13:02 - 08-May-26 |
| Sell* | 165 | 6.70p | SI Trade |
13:45:09 - 08-May-26 |
| Buy* | 6,191 | 6.90p | SI Trade |
13:45:09 - 08-May-26 |
| Buy* | 1,015 | 6.90p | SI Trade |
13:45:09 - 08-May-26 |
| Buy* | 21 | 6.90p | SI Trade |
13:45:09 - 08-May-26 |
| Buy* | 28 | 6.90p | SI Trade |
13:45:09 - 08-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
